出居 真由美

In Vitro Diagnostics for SARS-CoV-2 Infection Authorized in the United States and Approved in Japan. 

Clinical and translational science 18(11) e70402 2025年11月  査読有り筆頭著者責任著者

順天堂大学医学部附属順天堂医院におけるアミラーゼのクリティカ ルバリュー （パニック値）報告の現状と設定値の妥当性に関する検討 

日本臨床検査医学会誌 73(4) 249-255 2025年4月  査読有り責任著者

腹膜透析における腹膜劣化の評価方法 新規腹膜劣化指標としてERC/mesothelinの有用性 

臨床化学 52(3) 186-192 2023年7月  筆頭著者

A cross-sectional survey on principal investigators' clinical research knowledge in Japan. 

Clinical and translational science 16(3) 459-466 2023年3月  査読有り

Effluent N-terminal expressed in renal cell carcinoma/mesothelin predicts increased peritoneal permeability in patients undergoing peritoneal dialysis. 

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 26(5) 1014-1022 2022年10月  査読有り筆頭著者責任著者

Meals and Room Temperature Storage do not Significantly Affect Feasibility of Direct RT-PCR Tests for SARS-CoV-2 Using Saliva. 

Clinical laboratory 68(6) 2022年6月1日  査読有り

腹膜透析患者における腹膜劣化の指標 

日本臨床検査医学会誌 69(7) 487-492 2021年7月  査読有り筆頭著者責任著者

SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo. 

Scientific reports 11(1) 8380-8380 2021年4月16日  査読有り

Achievements and challenges of the Sakigake designation system in Japan 

British Journal of Clinical Pharmacology 87(10) 4027-4035 2021年3月10日  査読有り

Rationales of delay and difference in regulatory review by Japan, the United States, and Europe among new drugs first approved in Japan 

British Journal of Clinical Pharmacology 87(8) 3279-3291 2021年1月28日  査読有り

Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients. 

PloS one 16(4) e0249449 2021年  査読有り

Comparison of the clinical performance and usefulness of five SARS-CoV-2 antibody tests. 

PloS one 16(2) e0246536 2021年  査読有り

Evolving landscape of new drug approval in Japan and lags from international birth dates: retrospective regulatory analysis. 

Clinical pharmacology and therapeutics 2020年10月13日  査読有り

Health-related quality of life on combination therapy with peritoneal dialysis and hemodialysis in comparison with hemodialysis and peritoneal dialysis: A cross-sectional study. 

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 40(5) 462-469 2020年9月  査読有り

Preβ1-high-density lipoprotein metabolism is delayed in patients with chronic kidney disease not on hemodialysis. 

Journal of clinical lipidology 14(5) 730-739 2020年8月6日  査読有り

Bioimpedance Spectroscopy-Based Fluid Status in Combined Dialysis Compared With Hemodialysis and Peritoneal Dialysis: A Cross-Sectional Study. 

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 24(4) 373-379 2020年8月  査読有り

Ultrafiltration volume by once-weekly hemodialysis is a predictor of technique survival of combination therapy with peritoneal dialysis and hemodialysis. 

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 25(1) 82-87 2020年5月8日  査読有り

Hospitalization for Patients on Combination Therapy With Peritoneal Dialysis and Hemodialysis Compared With Hemodialysis. 

Kidney international reports 5(4) 468-474 2020年4月  査読有り

Apolipoproteins C-II and C-III as nutritional markers unaffected by inflammation. 

Clinica chimica acta; international journal of clinical chemistry 481 225-230 2018年6月  査読有り